The manufacturing process for B-domain deleted recombinant factor VIII-Reference-Cited by-同舟云学术

The manufacturing process for B-domain deleted recombinant factor VIII

Published:2001-04 Issue: Volume:38 Page:24-31
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Eriksson R.K,Fenge C,Lindner-Olsson E,Ljungqvist C,Rosenquist J,Smeds A.-L,Östlin A,Charlebois T,Leonard M,Kelley B.D,Ljungqvist Å

Publisher

Elsevier BV

Subject

Hematology

Reference6 articles.

1. Second generation, B-domain deleted recombinant factor VIII;Berntorp;Thromb Haemost,1997

2. Structural and functional characteristics of a B-domain deleted recombinant factor VIII molecule, r-VIII SQ;Sandberg;Thromb Haemost,2001

3. Relationships among product characterization, process validation and preclinical/clinical studies for well characterized products;Lubiniecki;Dev Biol Stand,1998

4. Wyeth/Genetics Institute, Cambridge, MA, data on file

5. Process for purifying factor VIII;Almstedt,1998

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activity of transgene-produced B-domain–deleted factor VIII in human plasma following AAV5 gene therapy;Blood;2020-11-26

2. Affinity Chromatography: An Enabling Technology for Large‐Scale Bioprocessing;Biotechnology Journal;2019-10-25

3. Continuous and semi-continuous cell culture for production of blood clotting factors;Journal of Biotechnology;2015-11

4. Real-time quantitative PCR assay for rapid detection of murine virus contamination in bioproducts;Virologica Sinica;2014-05-15

5. Treatment of hemophilia: recombinant clotting factors;Contemporary Approaches to Hemophilia;2014-02